Clinical Trials Logo
  1. Home
  2. Graft Rejection
  3. NCT05072951
  4. Details
NCT05072951 Clinical Trial

Urine Biomarker for Kidney Transplant Rejection

Graft Rejection Clinical Trial

Official title:
An Adaptive Sample Collection to Evaluate a Biomarker for Kidney Transplant Rejection

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05072951
Other study ID # ECT2021-002
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 2021
Est. completion date October 2025

Study information
Verified date September 2021
Source Exosome Diagnostics, Inc.
Contact Sonia Kumar, PhD
Phone 7816939600
Email Sonia.Kumar@bio-techne.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An adaptive sample collection to support biomarker evaluation for kidney transplant rejection.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 750
Est. completion date October 2025
Est. primary completion date October 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Ability to provide informed consent - Kidney Transplant Exclusion Criteria: - Pediatric patients, under 18 years of age

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Urine Biomarker for Kidney Transplant Rejection
Biomarker for active kidney transplant rejection.

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Exosome Diagnostics, Inc.

Outcome
Type Measure Description Time frame Safety issue
Primary Biospecimen collection 3 years after last enrollment
See also
  Status Clinical Trial Phase
Completed NCT00771875 - Randomized Trial for Mixed Acute Rejection Phase 2
Completed NCT00369382 - Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients Phase 4
Completed NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome Phase 4
Completed NCT01211509 - Montelukast in Bronchiolitis Obliterans Syndrome Phase 4
Recruiting NCT01066689 - Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation Phase 3
Completed NCT00251004 - Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients Phase 3
Completed NCT00254709 - Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients Phase 4
Recruiting NCT04851145 - Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. N/A
Completed NCT00001984 - Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys Phase 2
Completed NCT04488094 - Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation Phase 2
Not yet recruiting NCT03147157 - The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation N/A
Completed NCT00761787 - Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY N/A
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Completed NCT00266123 - Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients Phase 4
Completed NCT00035555 - Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney Phase 2
Completed NCT00001858 - Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants
Completed NCT00895583 - Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Phase 4
Completed NCT00089947 - A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection Phase 2
Enrolling by invitation NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2
Active, not recruiting NCT00619528 - HLA-Identical Sibling Renal Transplant Tolerance N/A